ISHITA DRUGS Fact Sheet, ISHITA DRUGS Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ISHITA DRUGS Fact Sheet    (ISDR)


Revealed: How Fund Managers Spot Winning Stocks


Here is the latest financial fact sheet of ISHITA DRUGS. For more details, see the ISHITA DRUGS quarterly results and ISHITA DRUGS share price and chart. For a sector overview, read our pharmaceuticals sector report.

ISHITA DRUGS Price History

Price Rs 46.8
Mkt Cap Rs m 140
Vol '000 6.0
P/E X 16.9
P/CF X 19.3
EPS (TTM) Rs 2.8
% ch % 4.9
No. of shares m 2.99
% ch week % 27.2
% ch 1-mth % 56.0
% ch 12-mth % 188.9
52 week H/L Rs 46.8/15.5
(As on Jul 23, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

ISHITA DRUGS Financials

No. of Mths
Year Ending
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
ISHITA DRUGS EQUITY SHARE DATA
High Rs2123272322 
Low Rs1212151110 
Sales per share (Unadj.) Rs20.017.522.230.449.6 
Earnings per share (Unadj.) Rs0.50.60.81.21.8 
Diluted earnings per shareRs0.50.60.81.21.8 
Cash flow per share (Unadj.) Rs1.01.11.31.72.4 
Dividends per share (Unadj.) Rs00000 
Adj. dividends per shareRs0.000.000.000.000.00 
Dividend yield (eoy) %00000 
Book value per share (Unadj.) Rs18.819.420.321.523.3 
Adj. book value per shareRs18.819.420.321.423.3 
Shares outstanding (eoy) m2.992.992.992.992.99 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x0.81.00.90.60.3 
Avg P/E ratio x35.928.625.314.48.8 
P/CF ratio (eoy) x16.916.216.310.06.7 
Price / Book Value ratio x0.90.91.00.80.7 
Dividend payout %00000 
Avg Mkt Cap Rs m4952635148 
No. of employees `000NANANANANA 
Total wages/salary Rs m45678 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
ISHITA DRUGS INCOME DATA
Net Sales Rs m60526691148 
Other income Rs m22122 
Total revenues Rs m61546893150 
Gross profit Rs m23558 
Depreciation Rs m21122 
Interest Rs m10110 
Profit before tax Rs m23357 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m11112 
Profit after tax Rs m12245 
Gross profit margin %4.25.56.85.75.1 
Effective tax rate %28.729.023.324.023.3 
Net profit margin %2.33.53.73.93.7 
ISHITA DRUGS BALANCE SHEET DATA
Current assets Rs m6960586880 
Current liabilities Rs m251391724 
Net working cap to sales %73.488.872.355.938.1 
Current ratio x2.84.66.13.93.4 
Inventory Days Days135191176164132 
Debtors Days Days115119454732 
Net fixed assets Rs m1312141514 
Share capital Rs m3030303030 
"Free" reserves Rs m2628313440 
Net worth Rs m5658616470 
Long term debt Rs m00110 
Total assets Rs m8272728394 
Interest coverage x4.46.73.98.621.4 
Debt to equity ratio x00000 
Sales to assets ratio x0.70.70.91.11.6 
Return on assets %2.43.25.04.96.2 
Return on equity %2.43.14.15.57.9 
Return on capital %4.45.27.18.010.7 
Exports to sales %00000 
Imports to sales %32.329.823.610.418.5 
Exports (fob) Rs m00000 
Imports (cif) Rs m191616927 
Fx inflow Rs m24667 
Fx outflow Rs m1916161027 
Net fx Rs m-17-12-10-4-21 
ISHITA DRUGS CASH FLOW
From Operations Rs m 3 5 7 8 10 
From Investments Rs m -3 -6 -7 -11 -12 
From Financial Activity Rs m 11 -10 0 1 1 
Net Cashflow Rs m 11 -11 1 -2 0 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Indian Promoters 47.9%
Foreign collaborators 0.0%
Indian inst/Mut Fund 0.0%
FIIs 0.0%
ADR/GDR 0.0%
Free float 52.1%
Shareholders 4,425
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Survey No 179 / 1, Village : Vasna - Lyava, Taluka : Sanand Ahmedabad Dist, Vasna-lyava - 382170
E-MAIL NA WEB www.ishitadrugs.com
TEL 079 - 26468353 FAX 079 - 26404961
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT Bigshare Services Pvt Ltd, E-2/3 Ansa Industrial Estate, Saki Vihar Road, Saki Naka
YEAR OF INC: 1992 BSE CODE: 524400 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   FERMENTA BIOTECH  COMBAT DRUGS  ADVANCED ENZYME TECHNOLOGIES  IND. SWIFT  COLINZ LABOR  

Compare ISHITA DRUGS With:   FERMENTA BIOTECH  COMBAT DRUGS  ADVANCED ENZYME TECHNOLOGIES  IND. SWIFT  COLINZ LABOR  




Today's Market

Sensex Ends 139 Points Higher; ICICI Bank, Wipro and ITC Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Views on news

Why Did Pharma Stocks Surge? (Views On News)

Jul 17, 2021

A look into the factors contributing to the rally in pharma stocks.

Bajaj Healthcare Rallies 11% on DRDO Nod to Manufacture Oral Covid Drug (Views On News)

Jul 8, 2021

Bajaj Healthcare has more than doubled investors' wealth in the year 2021 so far. The counter has delivered over 240% return in the last one year.

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

KIMS Shares Make Strong Debut Listing at a 22% Premium (Views On News)

Jun 28, 2021

KIMS shares pare gains after making a strong debut on the exchanges.

What Led to the Recent Surge in Shares of Thyrocare Technologies? (Views On News)

Jun 26, 2021

Shares of Thyrocare Technologies rallied over 7% and touched an all time high of Rs 1,465 on the BSE yesterday.

More Views on News

Most Popular

A 25 Bagger Indian Stock at the Centre of the Global Semiconductor Chip Shortage (Profit Hunter)

Jul 13, 2021

One technology company in India is grossly underrated despite its dominant role in semiconductor chip designing.

RBI Opens a New Market for Investors (Fast Profits Daily)

Jul 16, 2021

You now have a new way to create wealth. Grab it with both hands.

OPEC is Dying! RIP OPEC (Fast Profits Daily)

Jul 13, 2021

Why the global oil cartel is unravelling and how India stands to gain.

A Better Way than the Zomato IPO to Play the Food Delivery Megatrend (Profit Hunter)

Jul 14, 2021

A unique backdoor way of making big profits from smallcap companies.

Top 3 Risks for the Nifty Today (Fast Profits Daily)

Jul 12, 2021

Don't ignore the risks to the Nifty that are hiding in plain sight.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK ISHITA DRUGS

  • Track your investment in ISHITA DRUGS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ISHITA DRUGS

ISHITA DRUGS - ACTAVIS COMPARISON

COMPARE ISHITA DRUGS WITH

MARKET STATS